AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer

BACKGROUND: AHNAK, also known as desmoyokin, is a giant protein with the molecular size of approximately 700 kDa and exerts diverse functions in different types of cancer. RESULTS: In the present study, we demonstrated that AHNAK mRNA levels were down-regulated in 7 out of 8 human breast cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bo, Wang, Jin, Dai, Danian, Zhou, Qingyu, Guo, Xiaofang, Tian, Zhi, Huang, Xiaojia, Yang, Lu, Tang, Hailin, Xie, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427595/
https://www.ncbi.nlm.nih.gov/pubmed/28494797
http://dx.doi.org/10.1186/s13046-017-0522-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427595/
https://www.ncbi.nlm.nih.gov/pubmed/28494797
http://dx.doi.org/10.1186/s13046-017-0522-4

Ejemplares similares